Market Insights Health Hospitals Inpatient Care

Treatment of Cardiovascular Diseases - Greece

Greece

The Treatment of Cardiovascular Diseases market in Greece is expected to witness a significant increase in revenue, reaching US$1.39bn in 2024.
This projection indicates a positive trend in the market's growth.
Furthermore, it is anticipated that the market will continue to expand at a compound annual growth rate (CAGR) of 2.20% between 2024 and 2029.
As a result, the market volume is expected to reach US$1.55bn by 2029.
When comparing the global market, it is noteworthy that in the United States is anticipated to generate the highest revenue, with a projected amount of US$136.00bn in 2024.
This indicates the dominance of the United States in the Treatment of Cardiovascular Diseases market on a global scale.
Despite economic challenges, Greece has made significant advancements in the treatment of cardiovascular diseases with the implementation of innovative medical technologies.

Key regions: China, India, United States, France, Canada

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.